Tara Moriarty

Associate Professor

Other Appointments

B.A., B.Sc., Ph.D.

Cross Appointments

Department of Laboratory Medicine and Pathobiology, Faculty of Medicine


Dr. Moriarty directs the Moriarty Lab, an infectious diseases research laboratory, in their study of blood-borne bacterial pathogens like Borrelia burgdorferi (the causative agent of Lyme disease).

Research & Clinical Specialties

Principal Investigator, Moriarty Lab

CIHR Bhagirath Singh Early Career Award in Infection and Immunity (2011)

Scientific Advisory Board Member for BEST in Genomics

Select Publications

Javid A, Zlotnikov N, PńõtroŇ°ov√° H, Tang TT, Zhang Y, Bansal AK, Ebady R, Parikh M, Ahmed M, Sun C, Newbigging S, Kim YR, Santana Sosa M, Glogauer M, Moriarty TJ. ‚ÄúHyperglycemia Impairs Neutrophil-Mediated Bacterial Clearance in Mice Infected with the Lyme Disease Pathogen.‚ÄĚ PLoS One. 2016 Jun 24;11(6).

Ogden NH, Feil EJ, Leighton PA, Lindsay LR, Margos G, Mechai S, Michel P, Moriarty TJ. ‚ÄúEvolutionary aspects of emerging Lyme disease in Canada.‚ÄĚ Appl Environ Microbiol. 2015 Nov;81(21):7350-9.

Lee WY, Sanz MJ, Wong CH, Hardy PO, Salman-Dilgimen A, Moriarty TJ, Chaconas G, Marques A, Krawetz R, Mody CH, Kubes P. ‚ÄúInvariant natural killer T cells act as an extravascular cytotoxic barrier for joint-invading Lyme Borrelia.‚ÄĚ Proc Natl Acad Sci U S A. 2014 Sep 23;111(38).